top of page

How oral healthcare is delivered is about to change....FOREVER.   Learn More

Amixicile: A Concept Therapeutic for Treatment of Chronic Anaerobic Infections

Updated: May 2, 2022

Source: British Journal of Gastroenterology (2019)

Amixicile is a selective anaerobic microbial therapeutic in development to treat chronic infections caused by anaerobic bacteria including periodontal disease and is designed for use for long term management of colitis caused by Clostrioides difficile.

Download PDF • 422KB

bottom of page